Skip to main
TDOC
TDOC logo

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 25%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health Inc. demonstrated significant growth in its Integrated Care segment, with membership rising to 102.5 million, an increase from 91.8 million a year prior and above the previous quarter's 93.8 million. The company reported an operating cash flow increase to $15.9 million year-over-year and finished the first quarter with cash and cash equivalents totaling $1,193.3 million, indicating solid financial health and liquidity. Although revenue growth for the upcoming quarter is modestly estimated at 3.5%, the stable customer acquisition cost trends and increasing membership point towards a positive outlook for the company's long-term performance.

Bears say

Teladoc Health Inc. has experienced a decline in its BetterHelp user base, falling to 397,000, which is down from both the previous quarter and the same quarter last year, indicating a concerning trend in user engagement. The company's reaffirmed FY25 topline guidance, while overshadowed by the anticipated negative impact of the Uplift initiative, has resulted in a reduction of EBITDA forecasts, reflecting potential challenges in achieving profitability. Additionally, the total revenue saw a year-over-year decline of 2.6%, largely driven by a 10.8% contraction in BetterHelp revenue, despite moderate growth in the Integrated Care segment, highlighting underlying issues within its core offerings.

Teladoc (TDOC) has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 25% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 16 analysts, Teladoc (TDOC) has a Hold consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.